Hinge Health (HNGE) holders report 1.5%–3.0% stakes in amended 13G/A

Rhea-AI Filing Summary

Hinge Health, Inc. received an amended Schedule 13G reporting updated beneficial ownership in its Class A Common Stock, par value $0.00001 per share. The filing covers shares underlying Class B Common Stock that are convertible into Class A on a 1‑for‑1 basis. Deer X Ltd and Deer X LP each report beneficial ownership of 1,908,707 shares, representing 3.0% of the Class A Common Stock. Bessemer Venture Partners X L.P. reports 984,511 shares or 1.6%, and Bessemer Venture Partners X Institutional L.P. reports 924,196 shares or 1.5%. All reporting persons state sole voting and dispositive power over their respective holdings. The percentages are based on 62,468,721 Class A shares outstanding as of July 29, 2026, as disclosed in the issuer’s Form 10‑Q.

Key Figures

Deer X Ltd beneficial ownership: 1,908,707 shares (3.0%) Deer X LP beneficial ownership: 1,908,707 shares (3.0%) BVP X beneficial ownership: 984,511 shares (1.6%) +2 more

5 metrics

Deer X Ltd beneficial ownership 1,908,707 shares (3.0%) Class A Common Stock equivalent based on Class B shares; as of July 29, 2026

Deer X LP beneficial ownership 1,908,707 shares (3.0%) Class A Common Stock equivalent based on Class B shares; as of July 29, 2026

BVP X beneficial ownership 984,511 shares (1.6%) Class A Common Stock equivalent based on Class B shares; as of July 29, 2026

BVP X Institutional beneficial ownership 924,196 shares (1.5%) Class A Common Stock equivalent based on Class B shares; as of July 29, 2026

Shares outstanding baseline 62,468,721 shares Hinge Health Class A Common Stock outstanding as of July 29, 2026

Key Terms

beneficially own, sole voting power, sole dispositive power, convertible, at the option of the holder, +1 more

5 terms

beneficially own financial

"may be deemed to beneficially own all 1,908,707 Shares held directly by the Funds"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

sole voting power financial

"5 | Sole Voting Power 984,511.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"7 | Sole Dispositive Power 1,908,707.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

convertible, at the option of the holder financial

"shares of Class B Common Stock are convertible, at the option of the holder, into shares"

general partner financial

"As the general partner of Deer X LP, which in turn is the general partner of the Funds"

A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.

FAQ

What ownership stakes in HNGE does Deer X report in this Schedule 13G/A?

Deer X Ltd and Deer X LP each report beneficial ownership of 1,908,707 shares of Hinge Health Class A Common Stock, representing 3.0% of the class, based on 62,468,721 shares outstanding as of July 29, 2026.

How many HNGE shares does Bessemer Venture Partners X L.P. beneficially own?

Bessemer Venture Partners X L.P. reports beneficial ownership of 984,511 shares of Hinge Health Class A Common Stock, equal to 1.6% of the outstanding Class A shares, calculated using 62,468,721 shares outstanding as of July 29, 2026.

What is Bessemer Venture Partners X Institutional L.P.’s stake in HNGE?

Bessemer Venture Partners X Institutional L.P. reports beneficial ownership of 924,196 shares of Hinge Health Class A Common Stock, representing 1.5% of the class, with percentages based on 62,468,721 Class A shares outstanding as of July 29, 2026.

Are the reported HNGE holdings based on convertible Class B shares?

Yes. The reporting persons state their holdings represent Class A Common Stock underlying shares of Class B Common Stock, which are convertible at the option of the holder into Class A on a 1‑for‑1 basis.

Do the HNGE reporting persons share voting or dispositive power over their holdings?

No shared powers are reported. Each reporting person lists sole voting power and sole dispositive power over its respective Hinge Health shares, with 0 shares under shared voting or dispositive power.

What outstanding share count is used to compute the HNGE ownership percentages?

All percentages are based on 62,468,721 shares of Hinge Health Class A Common Stock outstanding as of July 29, 2026, as disclosed in the company’s Quarterly Report on Form 10‑Q filed on August 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:21 PM Accepted by SEC EDGAR 08/14/2026 - 04:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Hinge Health, Inc.

(Name of Issuer)

Class A Common Stock, $0.00001 par value per share

(Title of Class of Securities)

433313103

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 433313103

1

Names of Reporting Persons

Bessemer Venture Partners X L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 984,511.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 984,511.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

984,511.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.6 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 62,468,721 shares of Class A Common Stock as of July 29, 2026 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.

SCHEDULE 13G

CUSIP Number(s): 433313103

1

Names of Reporting Persons

Bessemer Venture Partners X Institutional L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 924,196.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 924,196.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

924,196.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.5 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 62,468,721 shares of Class A Common Stock as of July 29, 2026 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.

SCHEDULE 13G

CUSIP Number(s): 433313103

1

Names of Reporting Persons

Deer X & Co. L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,908,707.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,908,707.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,908,707.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.0 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 62,468,721 shares of Class A Common Stock as of July 29, 2026 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.

SCHEDULE 13G

CUSIP Number(s): 433313103

1

Names of Reporting Persons

Deer X & Co. Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,908,707.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,908,707.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,908,707.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.0 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock beneficially owned by the Reporting Person, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned set forth in row 11 above is based on a total of 62,468,721 shares of Class A Common Stock as of July 29, 2026 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 Market Street, 7th Floor, San Francisco, CA 94105
Item 2.
(a)	Name of person filing: This statement is being filed by the following persons with respect to certain shares of Class B Common Stock (the "Shares" or the "Common Stock") of the Issuer. Bessemer Venture Partners X L.P. ("BVP X"), Bessemer Venture Partners X Institutional L.P. ("BVP X Inst" and together with BVP X, the "Funds") directly own shares of Common Stock. Deer X Ltd, Deer X LP, BVP X and BVP X Inst are sometimes individually referred to herein as a "Reporting Person" and collectively as the "Reporting Persons."
(b)	Address or principal business office or, if none, residence: The address of the principal business office of the Reporting Persons is: c/o Bessemer Venture Partners 1865 Palmer Avenue; Suite 104 Larchmont, NY 10583
(c)	Citizenship: Cayman Islands
(d)	Title of class of securities: Class A Common Stock, $0.00001 par value per share
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Deer X Ltd- 1,908,707 shares DeerX LP - 1,908,707 shares BVP X - 984,511 shares BVP X Inst - 924,196 shares
(b)	Percent of class: Deer X Ltd- 3.0% DeerX LP - 3.0% BVP X -1.6% BVP X Inst - 1.5% Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock of the Issuer beneficially owned by the Reporting Persons, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis. The percentage of shares beneficially owned is based on a total of 62,468,721 shares of Class A Common Stock outstanding as of July 29, 2026, as reported in the Issuer's Quartelry Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Deer X Ltd- 1,908,707 shares DeerX LP - 1,908,707 shares BVP X - 984,511 shares BVP X Inst - 924,196 shares
	(ii) Shared power to vote or to direct the vote: Deer X Ltd- 0 shares DeerX LP - 0 shares BVP X - 0 shares BVP X Inst - 0 shares
	(iii) Sole power to dispose or to direct the disposition of: Deer X Ltd- 1,908,707 shares DeerX LP - 1,908,707 shares BVP X - 984,511 shares BVP X Inst - 924,196 shares
	(iv) Shared power to dispose or to direct the disposition of: Deer X Ltd- 0 shares DeerX LP - 0 shares BVP X - 0 shares BVP X Inst - 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. As the general partner of Deer X LP, which in turn is the general partner of the Funds, Deer X Ltd may be deemed to beneficially own all 1,908,707 Shares held directly by the Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bessemer Venture Partners X L.P.

Signature:	/s/ Scott Ring
Name/Title:	Scott Ring, GC Deer X &Co. Ltd., the GP of Deer X & Co. L.P., the GP of Bessemer Venture Partners X, L.P.
Date:	08/14/2026

Bessemer Venture Partners X Institutional L.P.

Signature:	/s/ Scott Ring
Name/Title:	Scott Ring, GD Deer X&Co. Ltd., the GP of Deer X &Co. L.P., the GP of Bessemer Venture Partners X Institutional L.P.
Date:	08/14/2026

Deer X & Co. L.P.

Signature:	/s/ Scott Ring
Name/Title:	/s/ Scott Ring, General Counsel Deer X & Co. Ltd., the GP of Deer X & Co. L.P.
Date:	08/14/2026

Deer X & Co. Ltd.

Signature:	/s/ Scott Ring
Name/Title:	Scott Ring, General Counsel
Date:	08/14/2026